AtriCure (ATRC) Tops Q3 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.46 -1.18%
Revenue Growth %: +11.7%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.7%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $98.3 million versus the consensus estimate of $96.73 million.
GUIDANCE:
AtriCure sees FY2023 EPS of ($0.74)-($0.76), versus the consensus of ($0.92). AtriCure sees FY2023 revenue of $394-396 million, versus the consensus of $393.8 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
